{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:47:25Z","timestamp":1794008845733,"version":"4.8.0"},"reference-count":274,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biol Timing Sleep"],"DOI":"10.1038\/s44323-024-00007-z","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T15:02:47Z","timestamp":1725894167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Chronobiotic and cytoprotective activity of melatonin in the cardiovascular system. Doses matter"],"prefix":"10.1038","volume":"1","author":[{"given":"Daniel P.","family":"Cardinali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Vigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16466-1","volume":"23","author":"WSR Hasani","year":"2023","unstructured":"Hasani, W. S. R. et al. The global estimate of premature cardiovascular mortality: a systematic review and meta-analysis of age-standardized mortality rate. BMC Public Health 23, 1561 (2023).","journal-title":"BMC Public Health"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","volume":"82","author":"GA Mensah","year":"2023","unstructured":"Mensah, G. A. et al. Global burden of cardiovascular diseases and risks, 1990-2022. J. Am. Coll. Cardiol. 82, 2350\u20132473 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00281-020-00806-z","volume":"42","author":"F Barb\u00e9-Tuana","year":"2020","unstructured":"Barb\u00e9-Tuana, F., Funchal, G., Schmitz, C. R. R., Maurmann, R. M. & Bauer, M. E. The interplay between immunosenescence and age-related diseases. Semin. Immunopathol. 42, 545\u2013557 (2020).","journal-title":"Semin. Immunopathol."},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi, C., Garagnani, P., Parini, P., Giuliani, C. & Santoro, A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 14, 576\u2013590 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.smim.2018.09.003","volume":"40","author":"T Fulop","year":"2018","unstructured":"Fulop, T., Witkowski, J. M., Olivieri, F. & Larbi, A. The integration of inflammaging in age-related diseases. Semin. Immunol. 40, 17\u201335 (2018).","journal-title":"Semin. Immunol."},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.3390\/ijms23116350","volume":"23","author":"K Mi\u0144czuk","year":"2022","unstructured":"Mi\u0144czuk, K., Baranowska\u2010kuczko, M., Krzy\u017cewska, A., Schlicker, E. & Malinowska, B. Cross-talk between the (endo)cannabinoid and renin-angiotensin systems: basic evidence and potential therapeutic significance. Int. J. Mol. Sci. 23, 6350 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"7_CR7","first-page":"NACS.000622","volume":"5","author":"P Lissoni","year":"2021","unstructured":"Lissoni, P. How to modulate the immunoinflammatory biological response in cancer, autoimmunity and viral infections by a psychoneuroimmune approach. Nov. Approaches Cancer Study 5, NACS.000622 (2021).","journal-title":"Nov. Approaches Cancer Study"},{"key":"7_CR8","first-page":"789","volume":"35","author":"S Garc\u00eda","year":"2020","unstructured":"Garc\u00eda, S., Gim\u00e9nez, V. M. M., Mar\u00f3n, F. J. M., Reiter, R. J. & Manucha, W. Melatonin and cannabinoids: mitochondrial-targeted molecules that may reduce inflammaging in neurodegenerative diseases. Histol. Histopathol. 35, 789\u2013800 (2020).","journal-title":"Histol. Histopathol."},{"key":"7_CR9","first-page":"pgad455","volume":"3","author":"L Besedovsky","year":"2022","unstructured":"Besedovsky, L. et al. Differential effects of an experimental model of prolonged sleep disturbance on inflammation in healthy females and males. PNAS Nexus 3, pgad455 (2022).","journal-title":"PNAS Nexus"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2174\/1570159X20666220217152617","volume":"21","author":"F Cruz-Sanabria","year":"2023","unstructured":"Cruz-Sanabria, F. et al. Melatonin as a chronobiotic with sleep-promoting properties. Curr. Neuropharmacol. 21, 951\u2013987 (2023).","journal-title":"Curr. Neuropharmacol."},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1159\/000446543","volume":"104","author":"DP Cardinali","year":"2017","unstructured":"Cardinali, D. P. & Hardeland, R. Inflammaging, metabolic syndrome and melatonin: a call for treatment studies. Neuroendocrinology 104, 382\u2013397 (2017).","journal-title":"Neuroendocrinology"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1074248416660622","volume":"22","author":"SR Pandi-Perumal","year":"2017","unstructured":"Pandi-Perumal, S. R. et al. Melatonin and human cardiovascular disease. J. Cardiovasc Pharm. Ther. 22, 122\u2013132 (2017).","journal-title":"J. Cardiovasc Pharm. Ther."},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.jacbts.2023.03.024","volume":"8","author":"ME Young","year":"2023","unstructured":"Young, M. E. The cardiac circadian clock: implications for cardiovascular disease and its treatment. JACC Basic Transl. Sci. 8, 1613\u20131628 (2023).","journal-title":"JACC Basic Transl. Sci."},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"20190098","DOI":"10.1098\/rsfs.2019.0098","volume":"10","author":"RGSleep Foster","year":"2020","unstructured":"Foster, R. G. Sleep circadian rhythms and health. Interface Focus 10, 20190098 (2020).","journal-title":"Interface Focus"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/07487304231219206","volume":"39","author":"ML Jabbur","year":"2024","unstructured":"Jabbur, M. L., Dani, C., Spoelstra, K., Dodd, A. N. & Johnson, C. H. Evaluating the adaptive fitness of circadian clocks and their evolution. J. Biol. Rhythms 39, 115\u2013134 (2024).","journal-title":"J. Biol. Rhythms"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1016\/j.jmb.2020.03.009","volume":"432","author":"G Andreatta","year":"2020","unstructured":"Andreatta, G. & Tessmar-Raible, K. The still dark side of the moon: molecular mechanisms of lunar-controlled rhythms and clocks. J. Mol. Biol. 432, 3525\u20133546 (2020).","journal-title":"J. Mol. Biol."},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"eabe0465","DOI":"10.1126\/sciadv.abe0465","volume":"7","author":"L Casiraghi","year":"2021","unstructured":"Casiraghi, L. et al. Moonstruck sleep: synchronization of human sleep with the moon cycle under field conditions. Sci. Adv. 7, eabe0465 (2021).","journal-title":"Sci. Adv."},{"key":"7_CR18","doi-asserted-by":"crossref","unstructured":"Cardinali, D. P. Autonomic nervous system: basic and clinical aspects. Springer (2017).","DOI":"10.1007\/978-3-319-57571-1"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"R737","DOI":"10.1152\/ajpregu.1986.250.5.R737","volume":"250","author":"MC Moore-Ede","year":"1986","unstructured":"Moore-Ede, M. C. Physiology of the circadian timing system: predictive versus reactive homeostasis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 250, R737\u2013R752 (1986).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuropharm.2018.10.024","volume":"154","author":"D Burdakov","year":"2019","unstructured":"Burdakov, D. Reactive and predictive homeostasis: roles of orexin\/hypocretin neurons. Neuropharmacology 154, 61\u201367 (2019).","journal-title":"Neuropharmacology"},{"key":"7_CR21","doi-asserted-by":"crossref","unstructured":"Klerman, E. B., Dijk, D. J., Kronauer, R. E. & Czeisler, C. A. Simulations of light effects on the human circadian pacemaker: implications for assessment of intrinsic period. Am. J. Physiol. 270, R271\u2013R282 (1996).","DOI":"10.1152\/ajpregu.1996.270.1.R271"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41583-018-0026-z","volume":"19","author":"MH Hastings","year":"2018","unstructured":"Hastings, M. H., Maywood, E. S. & Brancaccio, M. Generation of circadian rhythms in the suprachiasmatic nucleus. Nat. Rev. Neurosci. 19, 453\u2013469 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1016\/j.jmb.2020.01.019","volume":"432","author":"MH Hastings","year":"2020","unstructured":"Hastings, M. H., Smyllie, N. J. & Patton, A. P. Molecular-genetic manipulation of the suprachiasmatic nucleus circadian clock. J. Mol. Biol. 432, 3639\u20133660 (2020).","journal-title":"J. Mol. Biol."},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1016\/j.jmb.2019.12.036","volume":"432","author":"PS Welz","year":"2020","unstructured":"Welz, P. S. & Benitah, S. A. Molecular connections between circadian clocks and aging. J. Mol. Biol. 432, 3661\u20133679 (2020).","journal-title":"J. Mol. Biol."},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nrg.2016.150","volume":"18","author":"JS Takahashi","year":"2017","unstructured":"Takahashi, J. S. Transcriptional architecture of the mammalian circadian clock. Nat. Rev. Genet. 18, 164\u2013179 (2017).","journal-title":"Nat. Rev. Genet."},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0092-8674(01)00610-9","volume":"107","author":"C Lee","year":"2001","unstructured":"Lee, C., Etchegaray, J. P., Cagampang, F. R. A., Loudon, A. S. I. & Reppert, S. M. Posttranslational mechanisms regulate the mammalian circadian clock. Cell 107, 855\u2013867 (2001).","journal-title":"Cell"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MOL.0b013e3280464ef6","volume":"18","author":"C Fontaine","year":"2007","unstructured":"Fontaine, C. & Staels, B. The orphan nuclear receptor Rev-erb\u03b1: a transcriptional link between circadian rhythmicity and cardiometabolic disease. Curr. Opin. Lipido 18, 141\u2013146 (2007).","journal-title":"Curr. Opin. Lipido"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/0470090839.ch7","volume":"253","author":"N Preitner","year":"2003","unstructured":"Preitner, N. et al. Orphan nuclear receptors, molecular clockwork, and the entrainment of peripheral oscillators. Novartis Found. Symp. 253, 89\u2013101 (2003).","journal-title":"Novartis Found. Symp."},{"key":"7_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98532-5","volume":"11","author":"D Ono","year":"2021","unstructured":"Ono, D. et al. CHRONO and DEC1\/DEC2 compensate for lack of CRY1\/CRY2 in expression of coherent circadian rhythm but not in generation of circadian oscillation in the neonatal mouse SCN. Sci. Rep. 11, 19240 (2021).","journal-title":"Sci. Rep."},{"key":"7_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/jsr.12371","volume":"25","author":"AA Borb\u00e9ly","year":"2016","unstructured":"Borb\u00e9ly, A. A., Daan, S., Wirz-Justice, A. & Deboer, T. The two-process model of sleep regulation: a reappraisal. J. Sleep. Res. 25, 131\u2013143 (2016).","journal-title":"J. Sleep. Res."},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.sleep.2020.02.004","volume":"70","author":"O Le Bon","year":"2020","unstructured":"Le Bon, O. Relationships between REM and NREM in the NREM-REM sleep cycle: a review on competing concepts. Sleep. Med. 70, 6\u201316 (2020).","journal-title":"Sleep. Med."},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1177\/074873049701200622","volume":"12","author":"P Lavie","year":"1997","unstructured":"Lavie, P. Melatonin: role in gating nocturnal rise in sleep propensity. J. Biol. Rhythms 12, 657\u2013665 (1997).","journal-title":"J. Biol. Rhythms"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1210\/jc.2010-1031","volume":"95","author":"A Lewy","year":"2010","unstructured":"Lewy, A. Clinical implications of the melatonin phase response curve. J. Clin. Endocrinol. Metab. 95, 3158\u20133160 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.sleep.2006.11.013","volume":"8","author":"DJ Skene","year":"2007","unstructured":"Skene, D. J. & Arendt, J. Circadian rhythm sleep disorders in the blind and their treatment with melatonin. Sleep. Med. 8, 651\u2013655 (2007).","journal-title":"Sleep. Med."},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"e12801","DOI":"10.1111\/jpi.12801","volume":"73","author":"JF Duffy","year":"2022","unstructured":"Duffy, J. F., Wang, W., Ronda, J. M. & Czeisler, C. A. High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults. J. Pineal Res. 73, e12801 (2022).","journal-title":"J. Pineal Res."},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jsmc.2020.02.015","volume":"15","author":"HJ Burgess","year":"2020","unstructured":"Burgess, H. J. & Emens, J. S. Drugs used in circadian sleep-wake rhythm disturbances. Sleep. Med. Clin. 15, 301\u2013310 (2020).","journal-title":"Sleep. Med. Clin."},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/0304-3940(93)90120-A","volume":"150","author":"RY Moore","year":"1993","unstructured":"Moore, R. Y. & Speh, J. C. GABA is the principal neurotransmitter of the circadian system. Neurosci. Lett. 150, 112\u2013116 (1993).","journal-title":"Neurosci. Lett."},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.autneu.2009.10.007","volume":"154","author":"DE Vigo","year":"2010","unstructured":"Vigo, D. E. et al. Nonlinear analysis of heart rate variability within independent frequency components during the sleep-wake cycle. Auton. Neurosci. 154, 84\u201388 (2010).","journal-title":"Auton. Neurosci."},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.coph.2021.01.002","volume":"57","author":"SS Thosar","year":"2021","unstructured":"Thosar, S. S. & Shea, S. A. Circadian control of human cardiovascular function. Curr. Opin. Pharm. 57, 89\u201397 (2021).","journal-title":"Curr. Opin. Pharm."},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1172\/JCI80590","volume":"128","author":"SS Thosar","year":"2018","unstructured":"Thosar, S. S., Butler, M. P. & Shea, S. A. Role of the circadian system in cardiovascular disease. J. Clin. Invest. 128, 2157\u20132167 (2018).","journal-title":"J. Clin. Invest."},{"key":"7_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/CIRCRESAHA.122.321369","volume":"132","author":"N El Jamal","year":"2023","unstructured":"El Jamal, N., Lordan, R., Teegarden, S. L., Grosser, T. & Fitzgerald, G. The circadian biology of heart failure. Circ. Res. 132, 223\u2013237 (2023).","journal-title":"Circ. Res."},{"key":"7_CR42","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/07420520902924939","volume":"26","author":"V Leibetseder","year":"2009","unstructured":"Leibetseder, V. et al. Clock genes display rhythmic expression in human hearts. Chronobiol. Int. 26, 621\u2013636 (2009).","journal-title":"Chronobiol. Int."},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s42003-023-05537-z","volume":"6","author":"MN Latimer","year":"2023","unstructured":"Latimer, M. N. et al. Cardiomyocyte-specific disruption of the circadian BMAL1\u2013REV-ERB\u03b1\/\u03b2 regulatory network impacts distinct miRNA species in the murine heart. Commun. Biol. 6, 1149 (2023).","journal-title":"Commun. Biol."},{"key":"7_CR44","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/07420528.2021.2011307","volume":"39","author":"EA Schroder","year":"2022","unstructured":"Schroder, E. A. et al. Timing of food intake in mice unmasks a role for the cardiomyocyte circadian clock mechanism in limiting QT-interval prolongation. Chronobiol. Int. 39, 525\u2013534 (2022).","journal-title":"Chronobiol. Int."},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"C954","DOI":"10.1152\/ajpcell.00383.2012","volume":"304","author":"EA Schroder","year":"2013","unstructured":"Schroder, E. A. et al. The cardiomyocyte molecular clock, regulation of Scn5a, and arrhythmia susceptibility. Am. J. Physiol. Cell Physiol. 304, C954\u2013C965 (2013).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"7_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20314-w","volume":"12","author":"EA Hayter","year":"2021","unstructured":"Hayter, E. A. et al. Distinct circadian mechanisms govern cardiac rhythms and susceptibility to arrhythmia. Nat. Commun. 12, 1\u201313 (2021).","journal-title":"Nat. Commun."},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"H1827","DOI":"10.1152\/ajpheart.00608.2015","volume":"309","author":"KA Ingle","year":"2015","unstructured":"Ingle, K. A. et al. Cardiomyocyte-specific Bmal1 deletion in mice triggers diastolic dysfunction, extracellular matrix response, and impaired resolution of inflammation. Am. J. Physiol. Heart Circ. Physiol. 309, H1827\u2013H1836 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s13238-020-00713-x","volume":"11","author":"E Li","year":"2020","unstructured":"Li, E. et al. BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy. Protein Cell 11, 661\u2013679 (2020).","journal-title":"Protein Cell"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"144302","DOI":"10.1016\/j.gene.2019.144302","volume":"730","author":"Y Bai","year":"2020","unstructured":"Bai, Y., Tang, L. & Li, L. The roles of ADIPOQ rs266729 and MTNR1B rs10830963 polymorphisms in patients with gestational diabetes mellitus: a meta-analysis. Gene 730, 144302 (2020).","journal-title":"Gene"},{"key":"7_CR50","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehad816","volume":"45","author":"D Malhan","year":"2024","unstructured":"Malhan, D. & Rel\u00f3gio, A. A matter of timing? The influence of circadian rhythms on cardiac physiology and disease. Eur. Heart J. 45, 561\u2013563 (2024).","journal-title":"Eur. Heart J."},{"key":"7_CR51","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/HYPERTENSIONAHA.106.083568","volume":"49","author":"TA Martino","year":"2007","unstructured":"Martino, T. A. et al. Disturbed diurnal rhythm alters gene expression and exacerbates cardiovascular disease with rescue by resynchronization. Hypertension 49, 1104\u20131113 (2007).","journal-title":"Hypertension"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"e942215","DOI":"10.12659\/MSM.942215","volume":"29","author":"J Lin","year":"2023","unstructured":"Lin, J. et al. Circadian rhythms in cardiovascular function: implications for cardiac diseases and therapeutic opportunities. Med. Sci. Monit. 29, e942215 (2023).","journal-title":"Med. Sci. Monit."},{"key":"7_CR53","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41569-019-0167-4","volume":"16","author":"S Crnko","year":"2019","unstructured":"Crnko, S., du Pr\u00e9, B. C., Sluijter, J. P. G. & van Laake, L. W. Circadian rhythms and the molecular clock in cardiovascular biology and disease. Nat. Rev. Cardiol. 16, 437\u2013447 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"7_CR54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11906-023-01274-0","volume":"26","author":"BM Shafer","year":"2024","unstructured":"Shafer, B. M., Kogan, S. A. & McHill, A. W. Pressure building against the clock: the impact of circadian misalignment on blood pressure. Curr. Hypertens. Rep. 26, 31\u201342 (2024).","journal-title":"Curr. Hypertens. Rep."},{"key":"7_CR55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/23328940.2017.1295128","volume":"4","author":"A Silvani","year":"2017","unstructured":"Silvani, A. Orexins and the cardiovascular events of awakening. Temperature (Austin) 4, 128\u2013140 (2017).","journal-title":"Temperature (Austin)"},{"key":"7_CR56","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2147\/CIA.S394749","volume":"18","author":"C Abulafia","year":"2023","unstructured":"Abulafia, C. et al. An exploratory study of sleep-wake differences of autonomic activity in patients with mild cognitive impairment: the role of melatonin as a modulating factor. Clin. Inter. Aging 18, 771\u2013781 (2023).","journal-title":"Clin. Inter. Aging"},{"key":"7_CR57","doi-asserted-by":"crossref","unstructured":"Vigo, D. E., Siri, L. N. & Cardinali, D. P. Heart rate variability: a tool to explore autonomic nervous system activity in health and disease. In: Psychiatry Neuroscience Update, 113\u2013126 (2018).","DOI":"10.1007\/978-3-319-95360-1_10"},{"key":"7_CR58","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fnins.2014.00402","volume":"8","author":"F Chouchou","year":"2014","unstructured":"Chouchou, F. & Desseilles, M. Heart rate variability: a tool to explore the sleeping brain? Front. Neurosci. 8, 402 (2014).","journal-title":"Front. Neurosci."},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1365-2869.2007.00581.x","volume":"16","author":"G Vandewalle","year":"2007","unstructured":"Vandewalle, G. et al. Robust circadian rhythm in heart rate and its variability: influence of exogenous melatonin and photoperiod. J. Sleep. Res. 16, 148\u2013155 (2007).","journal-title":"J. Sleep. Res."},{"key":"7_CR60","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s40265-017-0707-3","volume":"77","author":"JS Emens","year":"2017","unstructured":"Emens, J. S. & Eastman, C. I. Diagnosis and treatment of non-24-h sleep-wake disorder in the blind. Drugs 77, 637\u2013650 (2017).","journal-title":"Drugs"},{"key":"7_CR61","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.smrv.2016.06.005","volume":"34","author":"F Auld","year":"2017","unstructured":"Auld, F., Maschauer, E. L., Morrison, I., Skene, D. J. & Riha, R. L. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep. Med. Rev. 34, 10\u201322 (2017).","journal-title":"Sleep. Med. Rev."},{"key":"7_CR62","doi-asserted-by":"publisher","first-page":"e12544","DOI":"10.1111\/jpi.12544","volume":"66","author":"G Gobbi","year":"2019","unstructured":"Gobbi, G. & Comai, S. Sleep well. Untangling the role of melatonin MT1 and MT2 receptors in sleep. J. Pineal Res. 66, e12544 (2019).","journal-title":"J. Pineal Res."},{"key":"7_CR63","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fendo.2019.00087","volume":"10","author":"G Gobbi","year":"2019","unstructured":"Gobbi, G. & Comai, S. Differential function of melatonin MT1 and MT2 receptors in REM and NREM sleep. Front. Endocrinol. 10, 87 (2019).","journal-title":"Front. Endocrinol."},{"key":"7_CR64","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/B978-0-12-819975-6.00021-2","volume":"179","author":"P Pevet","year":"2021","unstructured":"Pevet, P., Challet, E. & Felder-Schmittbuhl, M. P. Melatonin and the circadian system: keys for health with a focus on sleep. Handb. Clin. Neurol. 179, 331\u2013343 (2021).","journal-title":"Handb. Clin. Neurol."},{"key":"7_CR65","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/978-1-4614-6199-9_19","volume":"784","author":"IJ Clarke","year":"2013","unstructured":"Clarke, I. J. & Caraty, A. Kisspeptin and seasonality of reproduction. Adv. Exp. Med. Biol. 784, 411\u2013430 (2013).","journal-title":"Adv. Exp. Med. Biol."},{"key":"7_CR66","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fendo.2018.00123","volume":"9","author":"F Wahab","year":"2018","unstructured":"Wahab, F., Atika, B., Ullah, F., Shahab, M. & Behr, R. Metabolic impact on the hypothalamic kisspeptin-kiss1r signaling pathway. Front. Endocrinol. (Lausanne) 9, 123 (2018).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"7_CR67","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/molecules23020301","volume":"23","author":"DX Tan","year":"2018","unstructured":"Tan, D. X., Xu, B., Zhou, X. & Reiter, R. J. Pineal calcification, melatonin production, aging, associated health consequences and rejuvenation of the pineal gland. Molecules 23, 301 (2018).","journal-title":"Molecules"},{"key":"7_CR68","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1124\/pr.110.002832","volume":"62","author":"ML Dubocovich","year":"2010","unstructured":"Dubocovich, M. L. et al. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharm. Rev. 62, 343\u2013380 (2010).","journal-title":"Pharm. Rev."},{"key":"7_CR69","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1111\/bph.13950","volume":"175","author":"E Cecon","year":"2018","unstructured":"Cecon, E., Oishi, A. & Jockers, R. Melatonin receptors: molecular pharmacology and signalling in the context of system bias. Br. J. Pharm. 175, 3263\u20133280 (2018).","journal-title":"Br. J. Pharm."},{"key":"7_CR70","doi-asserted-by":"publisher","first-page":"44","DOI":"10.32794\/mr11250011","volume":"2","author":"D-X Tan","year":"2019","unstructured":"Tan, D.-X. & Reiter, R. J. Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells. Melatonin Res. 2, 44\u201366 (2019).","journal-title":"Melatonin Res."},{"key":"7_CR71","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1210\/endo-91-5-1213","volume":"91","author":"DP Cardinali","year":"1972","unstructured":"Cardinali, D. P., Lynch, H. J. & Wurtman, R. J. Binding of melatonin to human and rat plasma proteins. Endocrinology 91, 1213\u20131218 (1972).","journal-title":"Endocrinology"},{"key":"7_CR72","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuchi.2015.03.002","volume":"61","author":"B Claustrat","year":"2015","unstructured":"Claustrat, B. & Leston, J. Melatonin: physiological effects in humans. Neurochirurgie 61, 77\u201384 (2015).","journal-title":"Neurochirurgie"},{"key":"7_CR73","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1007\/s00018-017-2609-7","volume":"74","author":"RJ Reiter","year":"2017","unstructured":"Reiter, R. J. et al. Melatonin as a mitochondria-targeted antioxidant: one of evolution\u2019s best ideas. Cell. Mol. Life Sci. 74, 3863\u20133881 (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"7_CR74","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1007\/s00018-014-1579-2","volume":"71","author":"D Acu\u00f1a-Castroviejo","year":"2014","unstructured":"Acu\u00f1a-Castroviejo, D. et al. Extrapineal melatonin: sources, regulation, and potential functions. Cell. Mol. Life Sci. 71, 2997\u20133025 (2014).","journal-title":"Cell. Mol. Life Sci."},{"key":"7_CR75","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s41782-020-00111-7","volume":"4","author":"DP Cardinali","year":"2020","unstructured":"Cardinali, D. P., Brown, G. M., Reiter, R. J. & Pandi-Perumal, S. R. Elderly as a high-risk group during COVID-19 pandemic: effect of circadian misalignment, sleep dysregulation and melatonin administration. Sleep. Vigil. 4, 81\u201387 (2020).","journal-title":"Sleep. Vigil."},{"key":"7_CR76","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1210\/er.2018-00084","volume":"39","author":"J Cipolla-Neto","year":"2018","unstructured":"Cipolla-Neto, J. & Do Amaral, F. G. Melatonin as a hormone: new physiological and clinical insights. Endocr. Rev. 39, 990\u20131028 (2018).","journal-title":"Endocr. Rev."},{"key":"7_CR77","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/biology12030383","volume":"12","author":"I Olejniczak","year":"2023","unstructured":"Olejniczak, I., Pilorz, V. & Oster, H. Circle(s) of life: the circadian clock from birth to death. Biology 12, 383 (2023).","journal-title":"Biology"},{"key":"7_CR78","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.physbeh.2013.04.006","volume":"118","author":"MP Terr\u00f3n","year":"2013","unstructured":"Terr\u00f3n, M. P. et al. Melatonin reduces body weight gain and increases nocturnal activity in male Wistar rats. Physiol. Behav. 118, 8\u201313 (2013).","journal-title":"Physiol. Behav."},{"key":"7_CR79","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2741\/S404","volume":"5","author":"M Zeman","year":"2013","unstructured":"Zeman, M. & Herichova, I. Melatonin and clock genes expression in the cardiovascular system. Front. Biosci. (Sch. Ed.) 5, 743\u2013753 (2013).","journal-title":"Front. Biosci. (Sch. Ed.)"},{"key":"7_CR80","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0306-4522(03)00344-0","volume":"120","author":"VJ Poirel","year":"2003","unstructured":"Poirel, V. J. et al. Contrary to other non-photic cues, acute melatonin injection does not induce immediate changes of clock gene mRNA expression in the rat suprachiasmatic nuclei. Neuroscience 120, 745\u2013755 (2003).","journal-title":"Neuroscience"},{"key":"7_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jpi.12189","volume":"58","author":"J Vriend","year":"2015","unstructured":"Vriend, J. & Reiter, R. J. Melatonin feedback on clock genes: a theory involving the proteasome. J. Pineal Res. 58, 1\u201311 (2015).","journal-title":"J. Pineal Res."},{"key":"7_CR82","doi-asserted-by":"publisher","first-page":"883637","DOI":"10.3389\/fphys.2022.883637","volume":"13","author":"M Pfeffer","year":"2022","unstructured":"Pfeffer, M., von Gall, C., Wicht, H. & Korf, H. W. The Role of the melatoninergic system in circadian and seasonal rhythms-insights from different mouse strains. Front. Physiol. 13, 883637 (2022).","journal-title":"Front. Physiol."},{"key":"7_CR83","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1097\/01.hjh.0000358833.41181.f6","volume":"27","author":"M Zeman","year":"2009","unstructured":"Zeman, M., Sz\u00e1nt\u00f3ov\u00e1, K., Stebelov\u00e1, K., Mravec, B. & Herichov\u00e1, I. Effect of rhythmic melatonin administration on clock gene expression in the suprachiasmatic nucleus and the heart of hypertensive TGR(mRen2)27 rats. J. Hypertens. Suppl. 27, S21\u2013S26 (2009).","journal-title":"J. Hypertens. Suppl."},{"key":"7_CR84","doi-asserted-by":"publisher","first-page":"bqad183","DOI":"10.1210\/endocr\/bqad183","volume":"165","author":"X Kong","year":"2023","unstructured":"Kong, X., Meerlo, P. & Hut, R. A. Melatonin does not affect the stress-induced phase shifts of peripheral clocks in male mice. Endocrinology 165, bqad183 (2023).","journal-title":"Endocrinology"},{"key":"7_CR85","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1007\/s00018-020-03713-6","volume":"78","author":"SK Soni","year":"2021","unstructured":"Soni, S. K. et al. Sirtuins and the circadian clock interplay in cardioprotection: focus on sirtuin 1. Cell Mol. Life Sci. 78, 2503\u20132515 (2021).","journal-title":"Cell Mol. Life Sci."},{"key":"7_CR86","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/ejn.14172","volume":"51","author":"L Yan","year":"2020","unstructured":"Yan, L., Smale, L. & Nunez, A. A. Circadian and photic modulation of daily rhythms in diurnal mammals. Eur. J. Neurosci. 51, 551\u2013566 (2020).","journal-title":"Eur. J. Neurosci."},{"key":"7_CR87","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00424-021-02545-y","volume":"473","author":"D Campos-Beltr\u00e1n","year":"2021","unstructured":"Campos-Beltr\u00e1n, D. & Marshall, L. Changes in sleep EEG with aging in humans and rodents. Pfl\u00fcgers Arch. - Eur. J. Physiol. 473, 841\u2013851 (2021).","journal-title":"Pfl\u00fcgers Arch. - Eur. J. Physiol."},{"key":"7_CR88","doi-asserted-by":"publisher","first-page":"e12928","DOI":"10.1111\/jpi.12928","volume":"76","author":"Y Wang","year":"2024","unstructured":"Wang, Y. & Deboer, T. Hypnotic effects of melatonin depend on the environmental lighting conditions in the rat. J. Pineal Res. 76, e12928 (2024).","journal-title":"J. Pineal Res."},{"key":"7_CR89","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jsmc.2009.02.007","volume":"4","author":"SMW Rajaratnam","year":"2009","unstructured":"Rajaratnam, S. M. W., Cohen, D. A. & Rogers, N. L. Melatonin and melatonin analogues. Sleep. Med. Clin. 4, 179\u2013193 (2009).","journal-title":"Sleep. Med. Clin."},{"key":"7_CR90","first-page":"14","volume":"49","author":"A Dominguez-Rodriguez","year":"2010","unstructured":"Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Sanchez-Sanchez, J. J., Kaski, J. C. & Reiter, R. J. Melatonin and circadian biology in human cardiovascular disease. J. Pineal Res. 49, 14\u201322 (2010).","journal-title":"J. Pineal Res."},{"key":"7_CR91","doi-asserted-by":"publisher","first-page":"888319","DOI":"10.3389\/fcvm.2022.888319","volume":"9","author":"M Tobeiha","year":"2022","unstructured":"Tobeiha, M. et al. Evidence for the benefits of melatonin in cardiovascular disease. Front. Cardiovasc. Med. 9, 888319 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"7_CR92","doi-asserted-by":"crossref","unstructured":"Cardinali, D. P., Pandi-Perumal, S. R. & Brown, G. M. Chapter 14. Melatonin as a chronobiotic and cytoprotector in healthy aging. In: a. Jagota (ed.), Sleep and Clocks in Aging and Longevity, Healthy Ageing and Longevity 18, Springer Nature Switzerland AG, pp 277\u2013312 (2023).","DOI":"10.1007\/978-3-031-22468-3_14"},{"key":"7_CR93","doi-asserted-by":"publisher","first-page":"640389","DOI":"10.1100\/2012\/640389","volume":"2012","author":"R Hardeland","year":"2012","unstructured":"Hardeland, R. Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction. Sci. World J. 2012, 640389 (2012).","journal-title":"Sci. World J."},{"key":"7_CR94","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.3390\/nu13103480","volume":"13","author":"C Vasey","year":"2021","unstructured":"Vasey, C., McBride, J. & Penta, K. Circadian rhythm dysregulation and restoration: the role of melatonin. Nutrients 13, 3480 (2021).","journal-title":"Nutrients"},{"key":"7_CR95","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0304-3940(02)00368-3","volume":"327","author":"A Altun","year":"2002","unstructured":"Altun, A. et al. Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X. Neurosci. Lett. 327, 143\u2013145 (2002).","journal-title":"Neurosci. Lett."},{"key":"7_CR96","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1034\/j.1600-079X.2000.290302.x","volume":"29","author":"L Girotti","year":"2000","unstructured":"Girotti, L. et al. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease. J. Pineal Res. 29, 138\u2013142 (2000).","journal-title":"J. Pineal Res."},{"key":"7_CR97","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1183\/09031936.00051906","volume":"30","author":"C Hern\u00e1ndez","year":"2007","unstructured":"Hern\u00e1ndez, C., Abreu, J., Abreu, P., Castro, A. & Jim\u00e9nez, A. Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP. Eur. Respir. J. 30, 496\u2013500 (2007).","journal-title":"Eur. Respir. J."},{"key":"7_CR98","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S0140-6736(95)91901-5","volume":"346","author":"E Nagtegaal","year":"1995","unstructured":"Nagtegaal, E. et al. Melatonin secretion and coronary heart disease. Lancet 346, 1299 (1995).","journal-title":"Lancet"},{"key":"7_CR99","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0167-5273(02)00461-8","volume":"89","author":"M Yaprak","year":"2003","unstructured":"Yaprak, M. et al. Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. Int. J. Cardiol. 89, 103\u2013107 (2003).","journal-title":"Int. J. Cardiol."},{"key":"7_CR100","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1038\/oby.2010.24","volume":"18","author":"S Contreras-Alcantara","year":"2010","unstructured":"Contreras-Alcantara, S., Baba, K. & Tosini, G. Removal of melatonin receptor type 1 induces insulin resistance in the mouse. Obesity 18, 1861\u20131863 (2010).","journal-title":"Obesity"},{"key":"7_CR101","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11357-012-9397-7","volume":"35","author":"S Cuesta","year":"2013","unstructured":"Cuesta, S. et al. Melatonin can improve insulin resistance and aging-induced pancreas alterations in senescence-accelerated prone male mice (SAMP8). Age (Dordr.) 35, 659\u2013671 (2013).","journal-title":"Age (Dordr.)"},{"key":"7_CR102","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/19382014.2020.1783162","volume":"12","author":"YH Lee","year":"2020","unstructured":"Lee, Y. H. et al. Melatonin protects INS-1 pancreatic \u03b2-cells from apoptosis and senescence induced by glucotoxicity and glucolipotoxicity. Islets 12, 87\u201398 (2020).","journal-title":"Islets"},{"key":"7_CR103","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s13238-014-0030-7","volume":"5","author":"Y Du","year":"2014","unstructured":"Du, Y. & Wei, T. Inputs and outputs of insulin receptor. Protein Cell 5, 203\u2013213 (2014).","journal-title":"Protein Cell"},{"key":"7_CR104","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.phrs.2009.01.005","volume":"59","author":"M She","year":"2009","unstructured":"She, M. et al. NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat\/high-sucrose-fed rats. Pharm. Res. 59, 248\u2013253 (2009).","journal-title":"Pharm. Res."},{"key":"7_CR105","doi-asserted-by":"crossref","unstructured":"Hardeland, R., Cardinali, D. P., Brown, G. M. & Pandi-Perumal, S. R. Melatonin and brain inflammaging. Prog. Neurobiol. 127\u2013128, 46\u201363 (2015).","DOI":"10.1016\/j.pneurobio.2015.02.001"},{"key":"7_CR106","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.3390\/ijms14048638","volume":"14","author":"A Carrillo-Vico","year":"2013","unstructured":"Carrillo-Vico, A., Lardone, P. J., \u00c1lvarez-\u015anchez, N., Rodr\u0129guez-Rodr\u0129guez, A. & Guerrero, J. M. Melatonin: buffering the immune system. Int. J. Mol. Sci. 14, 8638\u20138683 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"7_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20051223","volume":"20","author":"R Hardeland","year":"2019","unstructured":"Hardeland, R. Aging, melatonin, and the pro-and anti-inflammatory networks. Int. J. Mol. Sci. 20, 1\u201333 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"7_CR108","doi-asserted-by":"publisher","first-page":"12143","DOI":"10.3390\/ijms222212143","volume":"22","author":"RP Markus","year":"2021","unstructured":"Markus, R. P., Sousa, K. S., da Silveira Cruz-Machado, S., Fernandes, P. A. & Ferreira, Z. S. Possible role of pineal and extra-pineal melatonin in surveillance, immunity, and first-line defense. Int. J. Mol. Sci. 22, 12143 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"7_CR109","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1600-079X.2008.00606.x","volume":"45","author":"RA Kireev","year":"2008","unstructured":"Kireev, R. A. et al. Melatonin is able to prevent the liver of old castrated female rats from oxidative and pro-inflammatory damage. J. Pineal Res. 45, 394\u2013402 (2008).","journal-title":"J. Pineal Res."},{"key":"7_CR110","doi-asserted-by":"publisher","first-page":"9707","DOI":"10.1007\/s11357-014-9707-3","volume":"36","author":"RA Kireev","year":"2014","unstructured":"Kireev, R. A., Vara, E., Vi\u00f1a, J. & Tresguerres, J. A. F. Melatonin and oestrogen treatments were able to improve neuroinflammation and apoptotic processes in dentate gyrus of old ovariectomized female rats. Age (Dordr.) 36, 9707 (2014).","journal-title":"Age (Dordr.)"},{"key":"7_CR111","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.exger.2010.08.016","volume":"45","author":"S Cuesta","year":"2010","unstructured":"Cuesta, S. et al. Melatonin improves inflammation processes in liver of senescence-accelerated prone male mice (SAMP8). Exp. Gerontol. 45, 950\u2013956 (2010).","journal-title":"Exp. Gerontol."},{"key":"7_CR112","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.mad.2011.10.005","volume":"132","author":"S Cuesta","year":"2011","unstructured":"Cuesta, S. et al. Beneficial effect of melatonin treatment on inflammation, apoptosis and oxidative stress on pancreas of a senescence accelerated mice model. Mech. Ageing Dev. 132, 573\u2013582 (2011).","journal-title":"Mech. Ageing Dev."},{"key":"7_CR113","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/gerona\/glr083","volume":"66","author":"K Forman","year":"2011","unstructured":"Forman, K. et al. Effect of a combined treatment with growth hormone and melatonin in the cardiological aging on male SAMP8 mice. J. Gerontol. A Biol. Sci. Med. Sci. 66, 823\u2013834 (2011).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"7_CR114","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/diseases8040044","volume":"8","author":"DP Cardinali","year":"2020","unstructured":"Cardinali, D. P., Brown, G. M. & Pandi-Perumal, S. R. can melatonin be a potential \u2018silver bullet\u2019 in treating COVID-19 patients? Diseases 8, 44 (2020).","journal-title":"Diseases"},{"key":"7_CR115","doi-asserted-by":"publisher","first-page":"117583","DOI":"10.1016\/j.lfs.2020.117583","volume":"250","author":"R Zhang","year":"2020","unstructured":"Zhang, R. et al. COVID-19: melatonin as a potential adjuvant treatment. Life Sci. 250, 117583 (2020).","journal-title":"Life Sci."},{"key":"7_CR116","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10787-018-0539-0","volume":"27","author":"H Bazyar","year":"2019","unstructured":"Bazyar, H. et al. The effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 diabetes mellitus patients with chronic periodontitis: a double-blind, placebo-controlled trial. Inflammopharmacology 27, 67\u201376 (2019).","journal-title":"Inflammopharmacology"},{"key":"7_CR117","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.arcmed.2018.12.004","volume":"49","author":"AL S\u00e1nchez-L\u00f3pez","year":"2018","unstructured":"S\u00e1nchez-L\u00f3pez, A. L. et al. Efficacy of melatonin on serum pro-inflammatory cytokines and oxidative stress markers in relapsing remitting multiple sclerosis. Arch. Med. Res. 49, 391\u2013398 (2018).","journal-title":"Arch. Med. Res."},{"key":"7_CR118","doi-asserted-by":"publisher","first-page":"e11383","DOI":"10.1097\/MD.0000000000011383","volume":"97","author":"E Shafiei","year":"2018","unstructured":"Shafiei, E. et al. Effects of N-acetyl cysteine and melatonin on early reperfusion injury in patients undergoing coronary artery bypass grafting: a randomized, open-labeled, placebo-controlled trial. Medicine 97, e11383 (2018).","journal-title":"Medicine"},{"key":"7_CR119","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1600-079X.2007.00545.x","volume":"44","author":"B K\u00fcc\u00fckakin","year":"2008","unstructured":"K\u00fcc\u00fckakin, B. et al. Utility of melatonin to treat surgical stress after major vascular surgery - a safety study. J. Pineal Res. 44, 426\u2013431 (2008).","journal-title":"J. Pineal Res."},{"key":"7_CR120","doi-asserted-by":"publisher","first-page":"e12521","DOI":"10.1111\/jpi.12521","volume":"65","author":"Z Zhao","year":"2018","unstructured":"Zhao, Z. et al. The protective effect of melatonin on brain ischemia and reperfusion in rats and humans: In vivo assessment and a randomized controlled trial. J. Pineal Res. 65, e12521 (2018).","journal-title":"J. Pineal Res."},{"key":"7_CR121","first-page":"1197","volume":"44","author":"W Dai","year":"2019","unstructured":"Dai, W. et al. Melatonin prevents sepsis-induced renal injury via the PINK1\/Parkin1 signaling pathway. Int. J. Mol. Med. 44, 1197\u20131204 (2019).","journal-title":"Int. J. Mol. Med."},{"key":"7_CR122","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1002\/jcp.29190","volume":"235","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Melatonin attenuates ER stress and mitochondrial damage in septic cardiomyopathy: a new mechanism involving BAP31 upregulation and MAPK-ERK pathway. J. Cell Physiol. 235, 2847\u20132856 (2020).","journal-title":"J. Cell Physiol."},{"key":"7_CR123","doi-asserted-by":"publisher","first-page":"635083","DOI":"10.3389\/fcvm.2021.635083","volume":"8","author":"A Dom\u00ednguez-Rodr\u00edguez","year":"2021","unstructured":"Dom\u00ednguez-Rodr\u00edguez, A. et al. Melatonin and cardioprotection in humans: a systematic review and meta-analysis of randomized controlled trials. Front. Cardiovasc. Med. 8, 635083 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"7_CR124","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fphys.2018.00528","volume":"9","author":"Z Jiki","year":"2018","unstructured":"Jiki, Z., Lecour, S. & Nduhirabandi, F. Cardiovascular benefits of dietary melatonin: a myth or a reality? Front. Physiol. 9, 528 (2018).","journal-title":"Front. Physiol."},{"key":"7_CR125","doi-asserted-by":"crossref","unstructured":"Nduhirabandi, F. & Maarman, G. J. Melatonin in heart failure: a promising therapeutic strategy? Molecules 23, 1819 (2018).","DOI":"10.3390\/molecules23071819"},{"key":"7_CR126","first-page":"88","volume":"14","author":"RJ Reiter","year":"2024","unstructured":"Reiter, R. J. et al. Mitochondrial melatonin: beneficial effects in protecting against heart failure. Life (Basel) 14, 88 (2024).","journal-title":"Life (Basel)"},{"key":"7_CR127","doi-asserted-by":"publisher","first-page":"115305","DOI":"10.1016\/j.biopha.2023.115305","volume":"166","author":"AM Taha","year":"2023","unstructured":"Taha, A. M. et al. Melatonin as a potential treatment for septic cardiomyopathy. Biomed. Pharmacother. 166, 115305 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"7_CR128","doi-asserted-by":"publisher","first-page":"115475","DOI":"10.1016\/j.biopha.2023.115475","volume":"167","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Melatonin as a therapeutic agent for alleviating endothelial dysfunction in cardiovascular diseases: emphasis on oxidative stress. Biomed. Pharmacother. 167, 115475 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"7_CR129","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1182\/blood-2003-03-0779","volume":"102","author":"DB Boivin","year":"2003","unstructured":"Boivin, D. B. et al. Circadian clock genes oscillate in human peripheral blood mononuclear cells. Blood 102, 4143\u20134145 (2003).","journal-title":"Blood"},{"key":"7_CR130","doi-asserted-by":"publisher","first-page":"e29801","DOI":"10.1371\/journal.pone.0029801","volume":"6","author":"T Bollinger","year":"2011","unstructured":"Bollinger, T. et al. Circadian clocks in mouse and human CD4+ T cells. PLoS One 6, e29801 (2011).","journal-title":"PLoS One"},{"key":"7_CR131","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-079X.2011.00934.x","volume":"52","author":"R Hardeland","year":"2012","unstructured":"Hardeland, R., Madrid, J. A., Tan, D. X. & Reiter, R. J. Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J. Pineal Res. 52, 139\u2013166 (2012).","journal-title":"J. Pineal Res."},{"key":"7_CR132","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1600-079X.2010.00748.x","volume":"48","author":"KH Jung","year":"2010","unstructured":"Jung, K. H. et al. Melatonin ameliorates cerulein-induced pancreatitis by the modulation of nuclear erythroid 2-related factor 2 and nuclear factor-kappaB in rats. J. Pineal Res. 48, 239\u2013250 (2010).","journal-title":"J. Pineal Res."},{"key":"7_CR133","doi-asserted-by":"publisher","first-page":"12391","DOI":"10.1111\/jpi.12391","volume":"62","author":"JC Mayo","year":"2017","unstructured":"Mayo, J. C. et al. Melatonin and sirtuins: a \u2018not-so unexpected\u2019 relationship. J. Pineal Res. 62, 12391 (2017).","journal-title":"J. Pineal Res."},{"key":"7_CR134","doi-asserted-by":"publisher","first-page":"724506","DOI":"10.3389\/fphys.2021.724506","volume":"12","author":"M Watroba","year":"2021","unstructured":"Watroba, M. & Szukiewicz, D. Sirtuins at the service of healthy longevity. Front. Physiol. 12, 724506 (2021).","journal-title":"Front. Physiol."},{"key":"7_CR135","doi-asserted-by":"publisher","first-page":"746631","DOI":"10.3389\/fncel.2021.746631","volume":"15","author":"KKM Fernando","year":"2021","unstructured":"Fernando, K. K. M. & Wijayasinghe, Y. S. Sirtuins as potential therapeutic targets for mitigating neuroinflammation associated with Alzheimer\u2019s disease. Front. Cell Neurosci. 15, 746631 (2021).","journal-title":"Front. Cell Neurosci."},{"key":"7_CR136","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s11064-016-2110-y","volume":"42","author":"H J\u0119\u015bko","year":"2017","unstructured":"J\u0119\u015bko, H., Wencel, P., Strosznajder, R. P. & Strosznajder, J. B. Sirtuins and their roles in brain aging and neurodegenerative disorders. Neurochem. Res. 42, 876\u2013890 (2017).","journal-title":"Neurochem. Res."},{"key":"7_CR137","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00018-019-03438-1","volume":"77","author":"RJ Reiter","year":"2020","unstructured":"Reiter, R. J., Sharma, R., Ma, Q., Rorsales-Corral, S. & de Almeida Chuffa, L. G. Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis. Cell Mol. Life Sci. 77, 2527\u20132542 (2020).","journal-title":"Cell Mol. Life Sci."},{"key":"7_CR138","doi-asserted-by":"publisher","first-page":"e12547","DOI":"10.1111\/jpi.12547","volume":"66","author":"Y Xia","year":"2019","unstructured":"Xia, Y. et al. Melatonin in macrophage biology: Current understanding and future perspectives. J. Pineal Res. 66, e12547 (2019).","journal-title":"J. Pineal Res."},{"key":"7_CR139","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.bbabio.2017.09.005","volume":"1858","author":"KA Anderson","year":"2017","unstructured":"Anderson, K. A., Madsen, A. S., Olsen, C. A. & Hirschey, M. D. Metabolic control by sirtuins and other enzymes that sense NAD+, NADH, or their ratio. Biochim. Biophys. Acta Bioenerg. 1858, 991\u2013998 (2017).","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"7_CR140","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1042\/BST20190033","volume":"48","author":"HBS Griffiths","year":"2020","unstructured":"Griffiths, H. B. S., Williams, C., King, S. J. & Allison, S. J. Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target. Biochem. Soc. Trans. 48, 733\u2013744 (2020).","journal-title":"Biochem. Soc. Trans."},{"key":"7_CR141","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.lfs.2015.12.014","volume":"145","author":"S Emamgholipour","year":"2016","unstructured":"Emamgholipour, S., Hossein-Nezhad, A., Sahraian, M. A., Askarisadr, F. & Ansari, M. Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes. Life Sci. 145, 34\u201341 (2016).","journal-title":"Life Sci."},{"key":"7_CR142","doi-asserted-by":"publisher","first-page":"7968452","DOI":"10.1155\/2018\/7968452","volume":"2018","author":"F Bonomini","year":"2018","unstructured":"Bonomini, F., Favero, G., Rodella, L. F., Moghadasian, M. H. & Rezzani, R. Melatonin modulation of sirtuin-1 attenuates liver injury in a hypercholesterolemic mouse model. Biomed. Res. Int. 2018, 7968452 (2018).","journal-title":"Biomed. Res. Int."},{"key":"7_CR143","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/cells8091053","volume":"8","author":"A Stacchiotti","year":"2019","unstructured":"Stacchiotti, A. et al. Melatonin Effects on non-alcoholic fatty liver disease are related to microrna-34a-5p\/sirt1 axis and autophagy. Cells 8, 1053 (2019).","journal-title":"Cells"},{"key":"7_CR144","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fphys.2020.00103","volume":"11","author":"G Favero","year":"2020","unstructured":"Favero, G., Franco, C., Stacchiotti, A., Rodella, L. F. & Rezzani, R. Sirtuin1 role in the melatonin protective effects against obesity-related heart injury. Front. Physiol. 11, 103 (2020).","journal-title":"Front. Physiol."},{"key":"7_CR145","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/jpi.12161","volume":"57","author":"L Yu","year":"2014","unstructured":"Yu, L. et al. Melatonin receptor-mediated protection against myocardial ischemia\/reperfusion injury: role of SIRT1. J. Pineal Res. 57, 228\u2013238 (2014).","journal-title":"J. Pineal Res."},{"key":"7_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/srep32199","volume":"6","author":"XZ Bai","year":"2016","unstructured":"Bai, X. Z. et al. Melatonin prevents acute kidney injury in severely burned rats via the activation of SIRT1. Sci. Rep. 6, 32199 (2016).","journal-title":"Sci. Rep."},{"key":"7_CR147","doi-asserted-by":"publisher","first-page":"572911","DOI":"10.3389\/fphys.2020.572911","volume":"11","author":"A Owczarek","year":"2020","unstructured":"Owczarek, A. et al. Melatonin Lowers HIF-1\u03b1 content in human proximal tubular cells (HK-2) due to preventing its deacetylation by sirtuin 1. Front. Physiol. 11, 572911 (2020).","journal-title":"Front. Physiol."},{"key":"7_CR148","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/jpi.12254","volume":"59","author":"L Zhao","year":"2015","unstructured":"Zhao, L. et al. Melatonin alleviates brain injury in mice subjected to cecal ligation and puncture via attenuating inflammation, apoptosis, and oxidative stress: the role of SIRT1 signaling. J. Pineal Res. 59, 230\u2013239 (2015).","journal-title":"J. Pineal Res."},{"key":"7_CR149","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/bph.13751","volume":"174","author":"W Hu","year":"2017","unstructured":"Hu, W. et al. Utilizing melatonin to combat bacterial infections and septic injury. Br. J. Pharm. 174, 754\u2013768 (2017).","journal-title":"Br. J. Pharm."},{"key":"7_CR150","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3390\/antiox10081269","volume":"10","author":"RKA Sayed","year":"2021","unstructured":"Sayed, R. K. A. et al. The impact of melatonin supplementation and nlrp3 inflammasome deletion on age-accompanied cardiac damage. Antioxidants 10, 1269 (2021).","journal-title":"Antioxidants"},{"key":"7_CR151","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.2147\/JIR.S317672","volume":"14","author":"R Zheng","year":"2021","unstructured":"Zheng, R. et al. Melatonin attenuates neuroinflammation by down-regulating NLRP3 inflammasome via a sirt1-dependent pathway in MPTP-induced models of Parkinson\u2019s disease. J. Inflamm. Res. 14, 3063\u20133075 (2021).","journal-title":"J. Inflamm. Res."},{"key":"7_CR152","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/jpi.12303","volume":"60","author":"H Volt","year":"2016","unstructured":"Volt, H. et al. Same molecule but different expression: aging and sepsis trigger NLRP3 inflammasome activation, a target of melatonin. J. Pineal Res. 60, 193\u2013205 (2016).","journal-title":"J. Pineal Res."},{"key":"7_CR153","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.theriogenology.2021.11.020","volume":"179","author":"R Feng","year":"2022","unstructured":"Feng, R. et al. The ameliorative effect of melatonin on LPS-induced Sertoli cells inflammatory and tight junctions damage via suppression of the TLR4\/MyD88\/NF-\u03baB signaling pathway in newborn calf. Theriogenology 179, 103\u2013116 (2022).","journal-title":"Theriogenology"},{"key":"7_CR154","doi-asserted-by":"publisher","first-page":"110109","DOI":"10.1016\/j.pnpbp.2020.110109","volume":"111","author":"T Lwin","year":"2021","unstructured":"Lwin, T. et al. Melatonin ameliorates methamphetamine-induced cognitive impairments by inhibiting neuroinflammation via suppression of the TLR4\/MyD88\/NF\u03baB signaling pathway in the mouse hippocampus. Prog. Neuropsychopharmacol. Biol. Psychiatry 111, 110109 (2021).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"7_CR155","doi-asserted-by":"publisher","first-page":"13A","DOI":"10.1067\/mhj.2001.114368","volume":"141","author":"K Nishiyama","year":"2001","unstructured":"Nishiyama, K. et al. Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. Am. Heart J. 141, 13A (2001).","journal-title":"Am. Heart J."},{"key":"7_CR156","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/hr.2009.174","volume":"33","author":"T Rechci\u0144ski","year":"2010","unstructured":"Rechci\u0144ski, T., Trzos, E., Wierzbowska-Drabik, K., Krzemi\u0144ska-Paku\u0142a, M. & Kurpesa, M. Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability. Hypertens. Res. 33, 56\u201361 (2010).","journal-title":"Hypertens. Res."},{"key":"7_CR157","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fendo.2020.00239","volume":"11","author":"LA Campos","year":"2020","unstructured":"Campos, L. A. et al. Melatonin therapy improves cardiac autonomic modulation in pinealectomized patients. Front. Endocrinol. (Lausanne) 11, 239 (2020).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"7_CR158","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/1440-1681.12942","volume":"45","author":"J Baker","year":"2018","unstructured":"Baker, J. & Kimpinski, K. Role of melatonin in blood pressure regulation: an adjunct anti-hypertensive agent. Clin. Exp. Pharm. Physiol. 45, 755\u2013766 (2018).","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"7_CR159","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.amjhyper.2005.05.008","volume":"18","author":"A Cagnacci","year":"2005","unstructured":"Cagnacci, A. et al. Prolonged melatonin administration decreases nocturnal blood pressure in women. Am. J. Hypertens. 18, 1614\u20131618 (2005).","journal-title":"Am. J. Hypertens."},{"key":"7_CR160","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1034\/j.1600-079X.2000.290304.x","volume":"29","author":"A Cagnacci","year":"2000","unstructured":"Cagnacci, A. et al. Different circulatory response to melatonin in postmenopausal women without and with hormone replacement therapy. J. Pineal Res. 29, 152\u2013158 (2000).","journal-title":"J. Pineal Res."},{"key":"7_CR161","doi-asserted-by":"publisher","first-page":"17920","DOI":"10.3390\/ijms151017920","volume":"15","author":"O Pechanova","year":"2014","unstructured":"Pechanova, O., Paulis, L. & Simko, F. Peripheral and central effects of melatonin on blood pressure regulation. Int J. Mol. Sci. 15, 17920\u201317937 (2014).","journal-title":"Int J. Mol. Sci."},{"key":"7_CR162","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1080\/15287394.2017.1384171","volume":"80","author":"G Shao","year":"2017","unstructured":"Shao, G., Zhang, S., Nie, J., Li, J. & Tong, J. Effects of melatonin on mechanisms involved in hypertension using human umbilical vein endothelial cells. J. Toxicol. Environ. Health A 80, 1342\u20131348 (2017).","journal-title":"J. Toxicol. Environ. Health A"},{"key":"7_CR163","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1517\/13543784.2012.716037","volume":"21","author":"A Dominguez-Rodriguez","year":"2012","unstructured":"Dominguez-Rodriguez, A. Melatonin in cardiovascular disease. Expert Opin. Investig. Drugs 21, 1593\u20131596 (2012).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"7_CR164","doi-asserted-by":"publisher","first-page":"283180","DOI":"10.1155\/2014\/283180","volume":"2014","author":"YL Tain","year":"2014","unstructured":"Tain, Y. L., Huang, L. T., Hsu, C. N. & Lee, C. T. E. Melatonin therapy prevents programmed hypertension and nitric oxide deficiency in offspring exposed to maternal caloric restriction. Oxid. Med. Cell Longev. 2014, 283180 (2014).","journal-title":"Oxid. Med. Cell Longev."},{"key":"7_CR165","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1600-079X.1991.tb00468.x","volume":"11","author":"MI Vacas","year":"1991","unstructured":"Vacas, M. I. et al. Inhibition of human platelet aggregation and thromboxane B2 production by melatonin. Correlation with plasma melatonin levels. J. Pineal Res. 11, 135\u2013139 (1991).","journal-title":"J. Pineal Res."},{"key":"7_CR166","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0304-4165(96)00025-6","volume":"1290","author":"G Ben\u00edtez-King","year":"1996","unstructured":"Ben\u00edtez-King, G., R\u00edos, A., Mart\u00ednez, A. & Ant\u00f3n-Tay, F. In vitro inhibition of Ca2+\/calmodulin-dependent kinase II activity by melatonin. Biochim. Biophys. Acta 1290, 191\u2013196 (1996).","journal-title":"Biochim. Biophys. Acta"},{"key":"7_CR167","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/jpi.12272","volume":"59","author":"L Yu","year":"2015","unstructured":"Yu, L. et al. Membrane receptor-dependent Notch1\/Hes1 activation by melatonin protects against myocardial ischemia-reperfusion injury: in vivo and in vitro studies. J. Pineal Res. 59, 420\u2013433 (2015).","journal-title":"J. Pineal Res."},{"key":"7_CR168","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.bbadis.2017.11.023","volume":"1864","author":"LM Yu","year":"2018","unstructured":"Yu, L. M. et al. Melatonin protects diabetic heart against ischemia-reperfusion injury, role of membrane receptor-dependent cGMP-PKG activation. Biochim. Biophys. Acta Mol. Basis Dis. 1864, 563\u2013578 (2018).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"7_CR169","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.lfs.2019.04.057","volume":"228","author":"H Lan","year":"2019","unstructured":"Lan, H. et al. Melatonin protects circulatory death heart from ischemia\/reperfusion injury via the JAK2\/STAT3 signalling pathway. Life Sci. 228, 35\u201346 (2019).","journal-title":"Life Sci."},{"key":"7_CR170","doi-asserted-by":"publisher","first-page":"e02659","DOI":"10.1016\/j.heliyon.2019.e02659","volume":"5","author":"K Dube","year":"2019","unstructured":"Dube, K. et al. Melatonin has profound effects on mitochondrial dynamics in myocardial ischaemia\/reperfusion. Heliyon 5, e02659 (2019).","journal-title":"Heliyon"},{"key":"7_CR171","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/FJC.0000000000000626","volume":"73","author":"S Ma","year":"2019","unstructured":"Ma, S. & Dong, Z. Melatonin attenuates cardiac reperfusion stress by improving OPA1-related mitochondrial fusion in a Yap-Hippo pathway-dependent manner. J. Cardiovasc. Pharm. 73, 27\u201339 (2019).","journal-title":"J. Cardiovasc. Pharm."},{"key":"7_CR172","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1600-079X.2008.00601.x","volume":"45","author":"HM Yeung","year":"2008","unstructured":"Yeung, H. M., Hung, M. W. & Fung, M. L. Melatonin ameliorates calcium homeostasis in myocardial and ischemia-reperfusion injury in chronically hypoxic rats. J. Pineal Res. 45, 373\u2013382 (2008).","journal-title":"J. Pineal Res."},{"key":"7_CR173","doi-asserted-by":"publisher","first-page":"e12503","DOI":"10.1111\/jpi.12503","volume":"65","author":"H Zhou","year":"2018","unstructured":"Zhou, H. et al. Inhibitory effect of melatonin on necroptosis via repressing the Ripk3-PGAM5-CypD-mPTP pathway attenuates cardiac microvascular ischemia-reperfusion injury. J. Pineal Res. 65, e12503 (2018).","journal-title":"J. Pineal Res."},{"key":"7_CR174","first-page":"44","volume":"110","author":"S Hu","year":"2018","unstructured":"Hu, S., Zhu, P., Zhou, H., Zhang, Y. & Chen, Y. Melatonin-Induced protective effects on cardiomyocytes against reperfusion injury partly through modulation of IP3R and SERCA2a via activation of ERK1. Arq. Bras. Cardiol. 110, 44\u201351 (2018).","journal-title":"Arq. Bras. Cardiol."},{"key":"7_CR175","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/jpi.12085","volume":"55","author":"ZP Hu","year":"2013","unstructured":"Hu, Z. P. et al. Melatonin ameliorates vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the TLR4\/NF-\u03baB system in high-fat-fed rabbits. J. Pineal Res. 55, 388\u2013398 (2013).","journal-title":"J. Pineal Res."},{"key":"7_CR176","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1034\/j.1600-079x.2002.1o851.x","volume":"32","author":"ML Pita","year":"2002","unstructured":"Pita, M. L. et al. Long-term melatonin administration increases polyunsaturated fatty acid percentage in plasma lipids of hypercholesterolemic rats. J. Pineal Res. 32, 179\u2013186 (2002).","journal-title":"J. Pineal Res."},{"key":"7_CR177","doi-asserted-by":"publisher","first-page":"11363","DOI":"10.18632\/aging.202829","volume":"13","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Melatonin attenuates smoking-induced atherosclerosis by activating the Nrf2 pathway via NLRP3 inflammasomes in endothelial cells. Aging 13, 11363\u201311380 (2021).","journal-title":"Aging"},{"key":"7_CR178","doi-asserted-by":"publisher","first-page":"e12581","DOI":"10.1111\/jpi.12581","volume":"67","author":"S Ding","year":"2019","unstructured":"Ding, S. et al. Melatonin stabilizes rupture-prone vulnerable plaques via regulating macrophage polarization in a nuclear circadian receptor ROR\u03b1-dependent manner. J. Pineal Res. 67, e12581 (2019).","journal-title":"J. Pineal Res."},{"key":"7_CR179","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1097\/HJH.0000000000001979","volume":"37","author":"H Li","year":"2019","unstructured":"Li, H. et al. Melatonin enhances atherosclerotic plaque stability by inducing prolyl-4-hydroxylase \u03b11 expression. J. Hypertens. 37, 964\u2013971 (2019).","journal-title":"J. Hypertens."},{"key":"7_CR180","doi-asserted-by":"publisher","first-page":"106659","DOI":"10.1016\/j.vph.2020.106659","volume":"127","author":"ZP Hu","year":"2020","unstructured":"Hu, Z. P., Fang, X. L., Sheng, B., Guo, Y. & Yu, Y. Q. Melatonin inhibits macrophage infiltration and promotes plaque stabilization by upregulating anti-inflammatory HGF\/c-Met system in the atherosclerotic rabbit: USPIO-enhanced MRI assessment. Vasc. Pharm. 127, 106659 (2020).","journal-title":"Vasc. Pharm."},{"key":"7_CR181","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejphar.2010.06.065","volume":"644","author":"V Patel","year":"2010","unstructured":"Patel, V., Upaganlawar, A., Zalawadia, R. & Balaraman, R. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation. Eur. J. Pharm. 644, 160\u2013168 (2010).","journal-title":"Eur. J. Pharm."},{"key":"7_CR182","first-page":"1","volume":"17","author":"M Garakyaraghi","year":"2012","unstructured":"Garakyaraghi, M., Siavash, M. & Alizadeh, M. Effects of melatonin on left ventricular ejection fraction and functional class of patients with heart failure: a randomized, double-blind, placebo- controlled trial. J. Res. Med. Sci. 17, 1 (2012).","journal-title":"J. Res. Med. Sci."},{"key":"7_CR183","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/jpi.12054","volume":"55","author":"D Koyun","year":"2013","unstructured":"Koyun, D. et al. Melatonin protects against ischemic heart failure in rats. J. Pineal Res. 55, 138\u2013148 (2013).","journal-title":"J. Pineal Res."},{"key":"7_CR184","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.redox.2018.07.007","volume":"18","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Melatonin improves cardiac function in a mouse model of heart failure with preserved ejection fraction. Redox Biol. 18, 211\u2013221 (2018).","journal-title":"Redox Biol."},{"key":"7_CR185","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3390\/ijms19061555","volume":"19","author":"I Odinokova","year":"2018","unstructured":"Odinokova, I. et al. Effect of melatonin on rat heart mitochondria in acute heart failure in aged rats. Int. J. Mol. Sci. 19, 1555 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"7_CR186","doi-asserted-by":"publisher","first-page":"52","DOI":"10.18565\/cardio.2014.9.52-56","volume":"54","author":"YV Liskova","year":"2014","unstructured":"Liskova, Y. V., Salikova, S. P. & Stadnikov, A. A. [Extracellular matrix remodeling myocardium of the left ventricle rats with experimental heart failure after perindopril and melatonin administration]. Kardiologiia 54, 52\u201356 (2014).","journal-title":"Kardiologiia"},{"key":"7_CR187","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10557-020-07052-3","volume":"36","author":"MH Pourhanifeh","year":"2022","unstructured":"Pourhanifeh, M. H., Dehdashtian, E., Hosseinzadeh, A., Sezavar, S. H. & Mehrzadi, S. Clinical application of melatonin in the treatment of cardiovascular diseases: current evidence and new insights into the cardioprotective and cardiotherapeutic properties. Cardiovasc Drugs Ther. 36, 131\u2013155 (2022).","journal-title":"Cardiovasc Drugs Ther."},{"key":"7_CR188","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1096\/fj.14-269043","volume":"29","author":"OL Blanchard","year":"2015","unstructured":"Blanchard, O. L. & Smoliga, J. M. Translating dosages from animal models to human clinical trials-revisiting body surface area scaling. FASEB J. 29, 1629\u20131634 (2015).","journal-title":"FASEB J."},{"key":"7_CR189","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ddr.21461","volume":"79","author":"A Nair","year":"2018","unstructured":"Nair, A., Morsy, M. A. & Jacob, S. Dose translation between laboratory animals and human in preclinical and clinical phases of drug development. Drug Dev. Res. 79, 373\u2013382 (2018).","journal-title":"Drug Dev. Res."},{"key":"7_CR190","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan\u2010Shaw","year":"2008","unstructured":"Reagan\u2010Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 22, 659\u2013661 (2008).","journal-title":"FASEB J."},{"key":"7_CR191","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/jpi.12134","volume":"56","author":"HF Galley","year":"2014","unstructured":"Galley, H. F. et al. Melatonin as a potential therapy for sepsis: a phase i dose escalation study and an ex vivo whole blood model under conditions of sepsis. J. Pineal Res. 56, 427\u2013438 (2014).","journal-title":"J. Pineal Res."},{"key":"7_CR192","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40261-015-0368-5","volume":"36","author":"LPH Andersen","year":"2016","unstructured":"Andersen, L. P. H., G\u00f6genur, I., Rosenberg, J. & Reiter, R. J. The Safety of melatonin in humans. Clin. Drug Investig. 36, 169\u2013175 (2016).","journal-title":"Clin. Drug Investig."},{"key":"7_CR193","unstructured":"Sugden, D. Psychopharmacological effects of melatonin in mouse and rat. J. Pharmacol. Exp. Ther. 227, 587\u2013591 (1983)."},{"key":"7_CR194","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.2147\/NSS.S380465","volume":"14","author":"DP Cardinali","year":"2022","unstructured":"Cardinali, D. P., Brown, G. M. & Pandi-Perumal, S. R. Melatonin\u2019s benefits and risks as a therapy for sleep disturbances in the elderly: current insights. Nat. Sci. Sleep. 14, 1843\u20131855 (2022).","journal-title":"Nat. Sci. Sleep."},{"key":"7_CR195","doi-asserted-by":"publisher","first-page":"e12782","DOI":"10.1111\/jpi.12782","volume":"72","author":"Z Menczel Schrire","year":"2022","unstructured":"Menczel Schrire, Z. et al. Safety of higher doses of melatonin in adults: a systematic review and meta-analysis. J. Pineal Res. 72, e12782 (2022).","journal-title":"J. Pineal Res."},{"key":"7_CR196","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/jep.13071","volume":"25","author":"HTA Khan","year":"2019","unstructured":"Khan, H. T. A. Population ageing in a globalized world: risks and dilemmas? J. Eval. Clin. Pr. 25, 754\u2013760 (2019).","journal-title":"J. Eval. Clin. Pr."},{"key":"7_CR197","first-page":"391","volume":"23","author":"HE Castagnino","year":"2002","unstructured":"Castagnino, H. E. et al. Cytoprotection by melatonin and growth hormone in early rat myocardial infarction as revealed by Feulgen DNA staining. Neuroendocrinol. Lett. 23, 391\u2013395 (2002).","journal-title":"Neuroendocrinol. Lett."},{"key":"7_CR198","doi-asserted-by":"publisher","first-page":"491","DOI":"10.33549\/physiolres.930664","volume":"54","author":"E Sahna","year":"2005","unstructured":"Sahna, E., Parlakpinar, H., Turkoz, Y. & Acet, A. Protective effects of melatonin on myocardial ischemia-reperfusion induced infarct size and oxidative changes. Physiol. Res. 54, 491\u2013495 (2005).","journal-title":"Physiol. Res."},{"key":"7_CR199","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-079X.2006.00383.x","volume":"42","author":"S Bertuglia","year":"2007","unstructured":"Bertuglia, S. & Reiter, R. J. Melatonin reduces ventricular arrhythmias and preserves capillary perfusion during ischemia-reperfusion events in cardiomyopathic hamsters. J. Pineal Res. 42, 55\u201363 (2007).","journal-title":"J. Pineal Res."},{"key":"7_CR200","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3349\/ymj.2008.49.5.735","volume":"49","author":"H Ceyran","year":"2008","unstructured":"Ceyran, H. et al. The effect of high dose melatonin on cardiac ischemia- reperfusion injury. Yonsei Med. J. 49, 735\u2013741 (2008).","journal-title":"Yonsei Med. J."},{"key":"7_CR201","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3892\/mmr.2014.2753","volume":"11","author":"X Cheng","year":"2015","unstructured":"Cheng, X. et al. Melatonin alleviates myosin light chain kinase expression and activity via the mitogen-activated protein kinase pathway during atherosclerosis in rabbits. Mol. Med. Rep. 11, 99\u2013104 (2015).","journal-title":"Mol. Med. Rep."},{"key":"7_CR202","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/jpi.12269","volume":"59","author":"L Yu","year":"2015","unstructured":"Yu, L. et al. Reduced silent information regulator 1 signaling exacerbates myocardial ischemia-reperfusion injury in type 2 diabetic rats and the protective effect of melatonin. J. Pineal Res. 59, 376\u2013390 (2015).","journal-title":"J. Pineal Res."},{"key":"7_CR203","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.freeradbiomed.2016.06.015","volume":"97","author":"H Pei","year":"2016","unstructured":"Pei, H. et al. Melatonin prevents adverse myocardial infarction remodeling via Notch1\/Mfn2 pathway. Free Radic. Biol. Med. 97, 408\u2013417 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"7_CR204","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s10495-016-1246-1","volume":"21","author":"L Yu","year":"2016","unstructured":"Yu, L. et al. Melatonin reduces PERK-eIF2\u03b1-ATF4-mediated endoplasmic reticulum stress during myocardial ischemia-reperfusion injury: role of RISK and SAFE pathways interaction. Apoptosis 21, 809\u2013824 (2016).","journal-title":"Apoptosis"},{"key":"7_CR205","doi-asserted-by":"publisher","first-page":"12368","DOI":"10.1111\/jpi.12368","volume":"62","author":"J Hu","year":"2017","unstructured":"Hu, J. et al. Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting Mst1. J. Pineal Res. 62, 12368 (2017).","journal-title":"J. Pineal Res."},{"key":"7_CR206","doi-asserted-by":"publisher","first-page":"12371","DOI":"10.1111\/jpi.12371","volume":"62","author":"HF Pei","year":"2017","unstructured":"Pei, H. F. et al. Melatonin attenuates postmyocardial infarction injury via increasing Tom70 expression. J. Pineal Res. 62, 12371 (2017).","journal-title":"J. Pineal Res."},{"key":"7_CR207","doi-asserted-by":"publisher","first-page":"12419","DOI":"10.1111\/jpi.12419","volume":"63","author":"M Zhai","year":"2017","unstructured":"Zhai, M. et al. Melatonin ameliorates myocardial ischemia reperfusion injury through SIRT3-dependent regulation of oxidative stress and apoptosis. J. Pineal Res. 63, 12419 (2017).","journal-title":"J. Pineal Res."},{"key":"7_CR208","doi-asserted-by":"publisher","first-page":"12438","DOI":"10.1111\/jpi.12438","volume":"63","author":"H Zhou","year":"2017","unstructured":"Zhou, H. et al. Melatonin suppresses platelet activation and function against cardiac ischemia\/reperfusion injury via PPAR\u03b3\/FUNDC1\/mitophagy pathways. J. Pineal Res. 63, 12438 (2017).","journal-title":"J. Pineal Res."},{"key":"7_CR209","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1159\/000491474","volume":"47","author":"WR Chen","year":"2018","unstructured":"Chen, W. R. et al. Melatonin attenuates myocardial ischemia\/reperfusion injury by inhibiting autophagy via an AMPK\/mTOR signaling pathway. Cell Physiol. Biochem 47, 2067\u20132076 (2018).","journal-title":"Cell Physiol. Biochem"},{"key":"7_CR210","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1080\/10715762.2018.1461215","volume":"52","author":"J Feng","year":"2018","unstructured":"Feng, J. et al. Melatonin protects against myocardial ischemia-reperfusion injury by elevating Sirtuin3 expression and manganese superoxide dismutase activity. Free Radic. Res. 52, 840\u2013849 (2018).","journal-title":"Free Radic. Res."},{"key":"7_CR211","doi-asserted-by":"publisher","first-page":"9286458","DOI":"10.1155\/2018\/9286458","volume":"2018","author":"S Ma","year":"2018","unstructured":"Ma, S. et al. Melatonin ameliorates the progression of atherosclerosis via mitophagy activation and NLRP3 inflammasome inhibition. Oxid. Med. Cell Longev. 2018, 9286458 (2018).","journal-title":"Oxid. Med. Cell Longev."},{"key":"7_CR212","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.bbadis.2017.11.023","volume":"1864","author":"L Yu","year":"2018","unstructured":"Yu, L. ming et al. Melatonin protects diabetic heart against ischemia-reperfusion injury, role of membrane receptor-dependent cGMP-PKG activation. Biochim. Biophys. Acta Mol. Basis Dis. 1864, 563\u2013578 (2018).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"7_CR213","doi-asserted-by":"publisher","first-page":"e12589","DOI":"10.1111\/jpi.12589","volume":"67","author":"K Gul-Kahraman","year":"2019","unstructured":"Gul-Kahraman, K., Yilmaz-Bozoglan, M. & Sahna, E. Physiological and pharmacological effects of melatonin on remote ischemic perconditioning after myocardial ischemia-reperfusion injury in rats: role of Cybb, Fas, Nf\u03baB, Irisin signaling pathway. J. Pineal Res. 67, e12589 (2019).","journal-title":"J. Pineal Res."},{"key":"7_CR214","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1021\/acs.jafc.8b06217","volume":"67","author":"HY Li","year":"2019","unstructured":"Li, H. Y., Leu, Y. L., Wu, Y. C. & Wang, S. H. Melatonin inhibits in vitro smooth muscle cell inflammation and proliferation and atherosclerosis in apolipoprotein E-deficient mice. J. Agric. Food Chem. 67, 1889\u20131901 (2019).","journal-title":"J. Agric. Food Chem."},{"key":"7_CR215","doi-asserted-by":"publisher","first-page":"e12542","DOI":"10.1111\/jpi.12542","volume":"66","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion\/mitophagy and activating the AMPK-OPA1 signaling pathways. J. Pineal Res. 66, e12542 (2019).","journal-title":"J. Pineal Res."},{"key":"7_CR216","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/13813455.2020.1838550","volume":"129","author":"D Sezgin","year":"2023","unstructured":"Sezgin, D. et al. The effects of melatonin against atherosclerosis-induced endothelial dysfunction and inflammation in hypercholesterolemic rats. Arch. Physiol. Biochem. 129, 476\u2013483 (2023).","journal-title":"Arch. Physiol. Biochem."},{"key":"7_CR217","first-page":"3681","volume":"18","author":"L-F Liu","year":"2024","unstructured":"Liu, L.-F. et al. Protective effects of melatonin on ischemia-reperfusion induced myocardial damage and hemodynamic recovery in rats. Eur. Rev. Med. Pharm. Sci. 18, 3681\u20133686 (2024).","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"7_CR218","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0024-3205(98)00302-6","volume":"63","author":"I Morishima","year":"1998","unstructured":"Morishima, I. et al. Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats. Life Sci. 63, 511\u2013521 (1998).","journal-title":"Life Sci."},{"key":"7_CR219","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/030089160008600210","volume":"86","author":"MH Abdel Wahab","year":"2000","unstructured":"Abdel Wahab, M. H., Akoul, E. S. E. M. S. & Abdel-Aziz, A. A. H. Modulatory effects of melatonin and vitamin E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice. Tumori 86, 157\u2013162 (2000).","journal-title":"Tumori"},{"key":"7_CR220","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1034\/j.1600-079X.2001.310104.x","volume":"31","author":"MT Agapito","year":"2001","unstructured":"Agapito, M. T. et al. Protective effect of melatonin against adriamycin toxicity in the rat. J. Pineal Res. 31, 23\u201330 (2001).","journal-title":"J. Pineal Res."},{"key":"7_CR221","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1034\/j.1600-079X.2001.310403.x","volume":"31","author":"MF Xu","year":"2001","unstructured":"Xu, M. F., Ho, S., Qian, Z. M. & Tang, P. L. Melatonin protects against cardiac toxicity of doxorubicin in rat. J. Pineal Res. 31, 301\u2013307 (2001).","journal-title":"J. Pineal Res."},{"key":"7_CR222","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1078\/0940-2993-00217","volume":"53","author":"P Dzi\u0229giel","year":"2002","unstructured":"Dzi\u0229giel, P. et al. Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat. Exp. Toxicol. Pathol. 53, 433\u2013439 (2002).","journal-title":"Exp. Toxicol. Pathol."},{"key":"7_CR223","doi-asserted-by":"publisher","first-page":"H254","DOI":"10.1152\/ajpheart.01023.2001","volume":"283","author":"X Liu","year":"2002","unstructured":"Liu, X. et al. Melatonin as an effective protector against doxorubicin-induced cardiotoxicity. Am. J. Physiol. Heart Circ. Physiol. 283, H254\u2013H263 (2002).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"7_CR224","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.bmc.2004.10.066","volume":"13","author":"HH Ahmed","year":"2005","unstructured":"Ahmed, H. H., Mannaa, F., Elmegeed, G. A. & Doss, S. H. Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity. Bioorg. Med. Chem. 13, 1847\u20131857 (2005).","journal-title":"Bioorg. Med. Chem."},{"key":"7_CR225","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/jpi.12067","volume":"55","author":"MW Hung","year":"2013","unstructured":"Hung, M. W. et al. Melatonin ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in rats with chronic intermittent hypoxia. J. Pineal Res. 55, 247\u2013256 (2013).","journal-title":"J. Pineal Res."},{"key":"7_CR226","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1034\/j.1600-079X.2003.00084.x","volume":"35","author":"E Sahna","year":"2003","unstructured":"Sahna, E. et al. Melatonin protects against myocardial doxorubicin toxicity in rats: role of physiological concentrations. J. Pineal Res. 35, 257\u2013261 (2003).","journal-title":"J. Pineal Res."},{"key":"7_CR227","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/01.fjc.0000171750.97822.a2","volume":"46","author":"C Kim","year":"2005","unstructured":"Kim, C. et al. Modulation by melatonin of the cardiotoxic and antitumor activities of adriamycin. J. Cardiovasc. Pharm. 46, 200\u2013210 (2005).","journal-title":"J. Cardiovasc. Pharm."},{"key":"7_CR228","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00595-004-2879-1","volume":"35","author":"G \u015eener","year":"2005","unstructured":"\u015eener, G. et al. Melatonin protects against oxidative organ injury in a rat model of sepsis. Surg. Today 35, 52\u201359 (2005).","journal-title":"Surg. Today"},{"key":"7_CR229","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1600-079X.2006.00368.x","volume":"41","author":"R Rezzani","year":"2006","unstructured":"Rezzani, R. et al. Beneficial effects of melatonin in protecting against cyclosporine A-induced cardiotoxicity are receptor mediated. J. Pineal Res. 41, 288\u2013295 (2006).","journal-title":"J. Pineal Res."},{"key":"7_CR230","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11010-006-1153-9","volume":"282","author":"E \u00d6z","year":"2006","unstructured":"\u00d6z, E., Erba\u015f, D., S\u00fcr\u00fcc\u00fc, H. S. & D\u00fczg\u00fcn, E. Prevention of doxorubicin-induced cardiotoxicity by melatonin. Mol. Cell Biochem. 282, 31\u201337 (2006).","journal-title":"Mol. Cell Biochem."},{"key":"7_CR231","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1111\/j.1742-4658.2007.05755.x","volume":"274","author":"G Escames","year":"2007","unstructured":"Escames, G. et al. Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice. FEBS J. 274, 2135\u20132147 (2007).","journal-title":"FEBS J."},{"key":"7_CR232","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.acthis.2006.09.007","volume":"109","author":"A Guven","year":"2007","unstructured":"Guven, A. et al. Melatonin protects against epirubicin-induced cardiotoxicity. Acta Histochem. 109, 52\u201360 (2007).","journal-title":"Acta Histochem."},{"key":"7_CR233","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1600-079X.2010.00818.x","volume":"50","author":"M Ozturk","year":"2011","unstructured":"Ozturk, M. et al. Efficacy of melatonin, mercaptoethylguanidine and 1400\u2009W in doxorubicin- and trastuzumab-induced cardiotoxicity. J. Pineal Res. 50, 89\u201396 (2011).","journal-title":"J. Pineal Res."},{"key":"7_CR234","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4236\/pp.2013.48085","volume":"4","author":"AA Alghasham","year":"2013","unstructured":"Alghasham, A. A. Comparative assessment of melatonin-afforded protection in liver, kidney and heart of male mice against doxorubicin induced toxicity. Pharmacol. Pharm. 4, 590\u2013598 (2013).","journal-title":"Pharmacol. Pharm."},{"key":"7_CR235","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jpi.12033","volume":"55","author":"H Zhang","year":"2013","unstructured":"Zhang, H. et al. Melatonin improved rat cardiac mitochondria and survival rate in septic heart injury. J. Pineal Res. 55, 1\u20136 (2013).","journal-title":"J. Pineal Res."},{"key":"7_CR236","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.3892\/etm.2013.989","volume":"5","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Protective effect of melatonin against Adriamycin-induced cardiotoxicity. Exp. Ther. Med. 5, 1496\u20131500 (2013).","journal-title":"Exp. Ther. Med."},{"key":"7_CR237","doi-asserted-by":"publisher","first-page":"265","DOI":"10.5543\/tkda.2014.36089","volume":"42","author":"A Bilgino\u01e7lu","year":"2014","unstructured":"Bilgino\u01e7lu, A., Aydin, D., \u00d6zsoy, \u015e. & Ayg\u00fcn, H. Protective effect of melatonin on adriamycin-induced cardiotoxicity in rats. Turk. Kardiyol. Dern. Ars 42, 265\u2013273 (2014).","journal-title":"Turk. Kardiyol. Dern. Ars"},{"key":"7_CR238","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/jpi.12184","volume":"57","author":"H Jin","year":"2014","unstructured":"Jin, H. et al. Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells. J. Pineal Res. 57, 442\u2013450 (2014).","journal-title":"J. Pineal Res."},{"key":"7_CR239","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/jpi.12099","volume":"56","author":"F Ortiz","year":"2014","unstructured":"Ortiz, F. et al. The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS. J. Pineal Res. 56, 71\u201381 (2014).","journal-title":"J. Pineal Res."},{"key":"7_CR240","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/jpi.12154","volume":"57","author":"F Simko","year":"2014","unstructured":"Simko, F. et al. Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure. J. Pineal Res. 57, 177\u2013184 (2014).","journal-title":"J. Pineal Res."},{"key":"7_CR241","doi-asserted-by":"publisher","first-page":"703175","DOI":"10.1155\/2014\/703175","volume":"2014","author":"F Simko","year":"2014","unstructured":"Simko, F. et al. Hypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin. Mediat. Inflamm. 2014, 703175 (2014).","journal-title":"Mediat. Inflamm."},{"key":"7_CR242","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejphar.2014.12.002","volume":"747","author":"AH Amin","year":"2015","unstructured":"Amin, A. H., El-Missiry, M. A. & Othman, A. I. Melatonin ameliorates metabolic risk factors, modulates apoptotic proteins, and protects the rat heart against diabetes-induced apoptosis. Eur. J. Pharm. 747, 166\u2013173 (2015).","journal-title":"Eur. J. Pharm."},{"key":"7_CR243","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/jpi.12263","volume":"59","author":"G Maarman","year":"2015","unstructured":"Maarman, G. et al. Melatonin as a preventive and curative therapy against pulmonary hypertension. J. Pineal Res. 59, 343\u2013353 (2015).","journal-title":"J. Pineal Res."},{"key":"7_CR244","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00395-015-0526-1","volume":"111","author":"R An","year":"2016","unstructured":"An, R. et al. Melatonin attenuates sepsis-induced cardiac dysfunction via a PI3K\/Akt-dependent mechanism. Basic Res. Cardiol. 111, 1\u201315 (2016).","journal-title":"Basic Res. Cardiol."},{"key":"7_CR245","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mito.2015.12.010","volume":"27","author":"C Doerrier","year":"2016","unstructured":"Doerrier, C. et al. Permeabilized myocardial fibers as model to detect mitochondrial dysfunction during sepsis and melatonin effects without disruption of mitochondrial network. Mitochondrion 27, 56\u201363 (2016).","journal-title":"Mitochondrion"},{"key":"7_CR246","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5505\/ejm.2016.19483","volume":"21","author":"Z Erdogmus Ozgen","year":"2016","unstructured":"Erdogmus Ozgen, Z., Erdinc, M., Akkoc, H. & Kelle, I. Protective effects of melatonin on doxorubicin induced cardiotoxicity in isolated rat heart. East J. Med. 21, 119\u2013124 (2016).","journal-title":"East J. Med."},{"key":"7_CR247","doi-asserted-by":"publisher","first-page":"12433","DOI":"10.1111\/jpi.12433","volume":"63","author":"M Zhai","year":"2017","unstructured":"Zhai, M. et al. Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1\u03b2: in vivo and in vitro studies. J. Pineal Res. 63, 12433 (2017).","journal-title":"J. Pineal Res."},{"key":"7_CR248","doi-asserted-by":"publisher","first-page":"12418","DOI":"10.1111\/jpi.12418","volume":"63","author":"M Zhang","year":"2017","unstructured":"Zhang, M. et al. Melatonin protects against diabetic cardiomyopathy through Mst1\/Sirt3 signaling. J. Pineal Res. 63, 12418 (2017).","journal-title":"J. Pineal Res."},{"key":"7_CR249","doi-asserted-by":"publisher","first-page":"e12491","DOI":"10.1111\/jpi.12491","volume":"65","author":"M Ding","year":"2018","unstructured":"Ding, M. et al. Melatonin prevents Drp1-mediated mitochondrial fission in diabetic hearts through SIRT1-PGC1\u03b1 pathway. J. Pineal Res. 65, e12491 (2018).","journal-title":"J. Pineal Res."},{"key":"7_CR250","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.taap.2018.06.031","volume":"358","author":"J Govender","year":"2018","unstructured":"Govender, J., Loos, B., Marais, E. & Engelbrecht, A. M. Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: a possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity? Toxicol. Appl Pharmacol. 358, 86\u2013101 (2018).","journal-title":"Toxicol. Appl Pharmacol."},{"key":"7_CR251","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2018.08.032","volume":"129","author":"D Liu","year":"2018","unstructured":"Liu, D. et al. AMPK\/PGC1\u03b1 activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis. Free Radic. Biol. Med. 129, 59\u201372 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"7_CR252","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/molecules23030675","volume":"23","author":"P Pan","year":"2018","unstructured":"Pan, P., Zhang, H., Su, L., Wang, X. & Liu, D. Melatonin balance the autophagy and apoptosis by regulating UCP2 in the LPS-induced cardiomyopathy. Molecules 23, 675 (2018).","journal-title":"Molecules"},{"key":"7_CR253","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3389\/fphar.2018.01384","volume":"9","author":"Y Sang","year":"2018","unstructured":"Sang, Y. et al. Melatonin ameliorates Coxsackievirus B3-induced myocarditis by regulating apoptosis and autophagy. Front. Pharm. 9, 1384 (2018).","journal-title":"Front. Pharm."},{"key":"7_CR254","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1111\/jcmm.13802","volume":"22","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. Melatonin activates Parkin translocation and rescues the impaired mitophagy activity of diabetic cardiomyopathy through Mst1 inhibition. J. Cell Mol. Med. 22, 5132\u20135144 (2018).","journal-title":"J. Cell Mol. Med."},{"key":"7_CR255","doi-asserted-by":"publisher","first-page":"607","DOI":"10.4196\/kjpp.2018.22.6.607","volume":"22","author":"Y Wu","year":"2018","unstructured":"Wu, Y. et al. The effect of melatonin on cardio fibrosis in juvenile rats with pressure overload and deregulation of HDACs. Korean J. Physiol. Pharm. 22, 607\u2013616 (2018).","journal-title":"Korean J. Physiol. Pharm."},{"key":"7_CR256","first-page":"374","volume":"17","author":"FY Xiong","year":"2018","unstructured":"Xiong, F. Y. et al. Melatonin ameliorates myocardial apoptosis by suppressing endoplasmic reticulum stress in rats with long-term diabetic cardiomyopathy. Mol. Med. Rep. 17, 374\u2013381 (2018).","journal-title":"Mol. Med. Rep."},{"key":"7_CR257","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.yjmcc.2018.10.018","volume":"125","author":"Z Yang","year":"2018","unstructured":"Yang, Z. et al. Melatonin attenuates chronic pain related myocardial ischemic susceptibility through inhibiting RIP3-MLKL\/CaMKII dependent necroptosis. J. Mol. Cell Cardiol. 125, 185\u2013194 (2018).","journal-title":"J. Mol. Cell Cardiol."},{"key":"7_CR258","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cellsig.2018.03.012","volume":"47","author":"H Zhou","year":"2018","unstructured":"Zhou, H., Yue, Y., Wang, J., Ma, Q. & Chen, Y. Melatonin therapy for diabetic cardiomyopathy: a mechanism involving Syk-mitochondrial complex I-SERCA pathway. Cell Signal. 47, 88\u2013100 (2018).","journal-title":"Cell Signal."},{"key":"7_CR259","first-page":"249","volume":"120","author":"H Aygun","year":"2019","unstructured":"Aygun, H. & Gul, S. S. Cardioprotective effect of melatonin and agomelatine on doxorubicin-induced cardiotoxicity in a rat model: an electrocardiographic, scintigraphic and biochemical study. Bratisl. Lek. Listy 120, 249\u2013255 (2019).","journal-title":"Bratisl. Lek. Listy"},{"key":"7_CR260","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.17219\/acem\/103799","volume":"28","author":"YB Kandemir","year":"2019","unstructured":"Kandemir, Y. B., Tosun, V. & G\u00fcntekin, \u00dc. Melatonin protects against streptozotocin-induced diabetic cardiomyopathy through the mammalian target of rapamycin (mTOR) signaling pathway. Adv. Clin. Exp. Med. 28, 1171\u20131177 (2019).","journal-title":"Adv. Clin. Exp. Med."},{"key":"7_CR261","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lfs.2018.11.055","volume":"217","author":"WX Zhang","year":"2019","unstructured":"Zhang, W. X., He, B. M., Wu, Y., Qiao, J. F. & Peng, Z. Y. Melatonin protects against sepsis-induced cardiac dysfunction by regulating apoptosis and autophagy via activation of SIRT1 in mice. Life Sci. 217, 8\u201315 (2019).","journal-title":"Life Sci."},{"key":"7_CR262","doi-asserted-by":"publisher","first-page":"101287","DOI":"10.1016\/j.redox.2019.101287","volume":"26","author":"J Zhong","year":"2019","unstructured":"Zhong, J. et al. Therapeutic contribution of melatonin to the treatment of septic cardiomyopathy: a novel mechanism linking Ripk3-modified mitochondrial performance and endoplasmic reticulum function. Redox Biol. 26, 101287 (2019).","journal-title":"Redox Biol."},{"key":"7_CR263","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1096\/fj.201902692R","volume":"34","author":"H Che","year":"2020","unstructured":"Che, H. et al. Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1\/miR-141-mediated NLRP3 inflammasome and TGF-\u03b21\/Smads signaling in diabetic cardiomyopathy. FASEB J. 34, 5282\u20135298 (2020).","journal-title":"FASEB J."},{"key":"7_CR264","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1111\/jcmm.15057","volume":"24","author":"HR Li","year":"2020","unstructured":"Li, H. R. et al. Melatonin attenuates doxorubicin-induced cardiotoxicity through preservation of YAP expression. J. Cell Mol. Med. 24, 3634\u20133646 (2020).","journal-title":"J. Cell Mol. Med."},{"key":"7_CR265","first-page":"753","volume":"121","author":"D Yildiz Pehlivan","year":"2020","unstructured":"Yildiz Pehlivan, D., Durdagi, G., Oz Oyar, E., Akyol, S. & Ozbek, M. The effects of melatonin and thymoquinone on doxorubicin-induced cardiotoxicity in rats. Bratisl. Lek. Listy 121, 753\u2013759 (2020).","journal-title":"Bratisl. Lek. Listy"},{"key":"7_CR266","doi-asserted-by":"publisher","first-page":"114743","DOI":"10.1016\/j.bcp.2021.114743","volume":"192","author":"A Arinno","year":"2021","unstructured":"Arinno, A. et al. Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics. Biochem. Pharm. 192, 114743 (2021).","journal-title":"Biochem. Pharm."},{"key":"7_CR267","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12012-020-09625-y","volume":"21","author":"G Durdagi","year":"2021","unstructured":"Durdagi, G., Pehlivan, D. Y., Oyar, E. O., Bahceci, S. A. & Ozbek, M. Effects of melatonin and adrenomedullin in reducing the cardiotoxic effects of doxorubicin in rats. Cardiovasc. Toxicol. 21, 354\u2013364 (2021).","journal-title":"Cardiovasc. Toxicol."},{"key":"7_CR268","doi-asserted-by":"publisher","first-page":"e12698","DOI":"10.1111\/jpi.12698","volume":"70","author":"LM Yu","year":"2021","unstructured":"Yu, L. M. et al. Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia-reperfusion injury by improving mitochondrial quality control: role of SIRT6. J. Pineal Res. 70, e12698 (2021).","journal-title":"J. Pineal Res."},{"key":"7_CR269","doi-asserted-by":"publisher","first-page":"1050598","DOI":"10.3389\/fphys.2022.1050598","volume":"13","author":"M Hanna","year":"2022","unstructured":"Hanna, M. et al. Synergistic cardioprotective effects of melatonin and deferoxamine through the improvement of ferritinophagy in doxorubicin-induced acute cardiotoxicity. Front. Physiol. 13, 1050598 (2022).","journal-title":"Front. Physiol."},{"key":"7_CR270","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/ph15070821","volume":"15","author":"H Tang","year":"2022","unstructured":"Tang, H. et al. Melatonin alleviates hyperglycemia-induced cardiomyocyte apoptosis via regulation of long non-coding RNA H19\/miR-29c\/MAPK Axis in diabetic cardiomyopathy. Pharmaceuticals 15, 821 (2022).","journal-title":"Pharmaceuticals"},{"key":"7_CR271","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/antiox12091716","volume":"12","author":"Y Ma","year":"2023","unstructured":"Ma, Y. et al. Melatonin restores autophagic flux by activating the Sirt3\/TFEB signaling pathway to attenuate doxorubicin-induced cardiomyopathy. Antioxidants 12, 1716 (2023).","journal-title":"Antioxidants"},{"key":"7_CR272","doi-asserted-by":"publisher","first-page":"e12884","DOI":"10.1111\/jpi.12884","volume":"75","author":"C Thonusin","year":"2023","unstructured":"Thonusin, C. et al. Effects of melatonin on cardiac metabolic reprogramming in doxorubicin-induced heart failure rats: a metabolomics study for potential therapeutic targets. J. Pineal Res. 75, e12884 (2023).","journal-title":"J. Pineal Res."},{"key":"7_CR273","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/biof.1934","volume":"49","author":"F Yarmohammadi","year":"2023","unstructured":"Yarmohammadi, F. et al. Melatonin ameliorates arsenic-induced cardiotoxicity through the regulation of the Sirt1\/Nrf2 pathway in rats. Biofactors 49, 620\u2013635 (2023).","journal-title":"Biofactors"},{"key":"7_CR274","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12933-023-02078-x","volume":"23","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Melatonin attenuates diabetic cardiomyopathy by increasing autophagy of cardiomyocytes via regulation of VEGF-B\/GRP78\/PERK signaling pathway. Cardiovasc. Diabetol. 23, 19 (2024).","journal-title":"Cardiovasc. Diabetol."}],"container-title":["npj Biological Timing and Sleep"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44323-024-00007-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44323-024-00007-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44323-024-00007-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T15:12:28Z","timestamp":1725894748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44323-024-00007-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":274,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["7"],"URL":"https:\/\/doi.org\/10.1038\/s44323-024-00007-z","relation":{},"ISSN":["2948-281X"],"issn-type":[{"value":"2948-281X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"assertion":[{"value":"21 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}